High Content & Phenotypic Screening 2017

Researchers from both Academia and Industry will come together to discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

The development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications will be discussed at this SELECTBIO meeting.

Topics for discussion include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Speakers include as Keynotes:

- Leo Price, CEO, OcellO B.V
- Lorenz Mayr, Vice President, AstraZeneca Ltd
- Jeffrey Morgan, Professor, Brown University

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Visit the website for up-to-date information, including poster submissions, and registration details.

On Tuesday April 25, 2017 at 8:00 am (ends Wednesday April 26, 2017 at 5:00 pm)

Category: Conferences - Science, Health & Medicine

Price:

Academic Delegate: GBP 449
Academic Delegate Early Bird: GBP 399
Industry Delegate: GBP 749
Industry Delegate Early Bird: GBP 649
Pre Doctoral Full Time Student (Inc. Poster): GBP 175

Venue: Holiday Inn Cambridge, Lakeview, Bridge Road, Cambridge, CB24 9PH

Links:

Tickets: https://go.evvnt.com/67298-0
Website: https://go.evvnt.com/67298-1